Mechanism for controlling the dimer-monomer switch and coupling dimerization to catalysis of the severe acute respiratory syndrome coronavirus 3C-like protease

Journal of Virology

Volumn 82, Issue 9, 2008, Pages 4620-4629

  Shi, Jiahai ^a   Sivaraman, J ^a   Song, Jianxing ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; MONOMER;

ARTICLE; CATALYSIS; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLIZATION; DIMERIZATION; ENZYME INACTIVATION; NONHUMAN; PRIORITY JOURNAL; SARS CORONAVIRUS; STRUCTURE ANALYSIS; ULTRACENTRIFUGE; VIRUS MUTATION;

AMINO ACID SUBSTITUTION; ARGININE; BINDING SITES; CATALYSIS; CRYSTALLOGRAPHY, X-RAY; CYSTEINE ENDOPEPTIDASES; DIMERIZATION; PROTEIN CONFORMATION; SARS VIRUS; VIRAL PROTEINS;

SARS CORONAVIRUS;

EID: 42449116132     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02680-07     Document Type: Article

References (32)

1. Allaire, M., M. M. Chernaia, B. A. Malcolm, and M. N. James. 1994. Picornaviral 3C cysteine proteinases have a fold similar to chymotrypsin-like serine proteinases. Nature 369:72-76.
2. Anand, K., G. J. Palm, J. R. Mesters, S. G. Siddell, J. Ziebuhr, and R. Hilgenfeld. 2002. Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain. EMBO J. 21:3213-3224.
3. Anand, K., J. Ziebuhr, P. Wadhwani, J. R. Mesters, and R. Hilgenfeld. 2003. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 300:1763-1767.
4. Barrila, J., U. Bacha, and E. Freire. 2006. Long-range cooperative interactions modulate dimerization in SARS 3CLpro. Biochemistry 45:14908-14916.
5. Brunger, A. T., P. D. Adams, G. M. Clore, W. L. DeLano, P. Gros, R. W. Grosse-Kunstleve, J. S. Jiang, J. Kuszewski, M. Nilges, N. S. Pannu, R. J. Read, L. M. Rice, T. Simonson, and G. L. Warren. 1998. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D 54:905-921.
6. Chang, H. P., C. Y. Chou, and G. G. Chang. 2007. Reversible unfolding of the severe acute respiratory syndrome coronavirus main protease in guanidinium chloride. Biophys. J. 92:1374-1383.
7. Chou, C. Y., H. C. Chang, W. C. Hsu, T. Z. Lin, C. H. Lin, and G. G. Chang. 2004. Quaternary structure of the severe acute respiratory syndrome (SARS) coronavirus main protease. Biochemistry 43:14958-14970.
8. Collaborative Computational Project, Number 4. 1994. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50:760-763.
9. Emsley, P., and K. Cowtan. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60:2126-2132.
10. Fan, K., P. Wei, Q. Feng, S. Chen, C. Huang, L. Ma, B. Lai, J. Pei, Y. Liu, J. Chen, and L. Lai. 2004. Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase. J. Biol. Chem. 279:1637-1642.
11. Graziano, V., W. J. McGrath, L. Yang, and W. F. Mangel. 2006. SARS CoV main proteinase: the monomer-dimer equilibrium dissociation constant. Biochemistry 45:14632-14641.
12. Hayward, S., and R. A. Lee. 2002. Improvements in the analysis of domain motions in proteins from conformational change: DynDom version 1.50. J. Mol. Graph. Model. 21:181-183.
13. Hsu, M. F., C. J. Kuo, K. T. Chang, H. C. Chang, C. C. Chou, T. P. Ko, H. L. Shr, G. G. Chang, A. H. Wang, and P. H. Liang. 2005. Mechanism of the maturation process of SARS-CoV 3CL protease. J. Biol. Chem. 280:31257-31266.
14. Hsu, W. C., H. C. Chang, C. Y. Chou, P. J. Tsai, P. I. Lin, and G. G. Chang. 2005. Critical assessment of important regions in the subunit association and catalytic action of the severe acute respiratory syndrome coronavirus main protease. J. Biol. Chem. 280:22741-22748.
15. Kuang, W. F., L. P. Chow, M. H. Wu, and L. H. Hwang. 2005. Mutational and inhibitive analysis of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer-based assays. Biochem. Biophys. Res. Commun. 331:1554-1559.
16. Kuo, C. J., Y. H. Chi, J. T. Hsu, and P. H. Liang. 2004. Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate. Biochem. Biophys. Res. Commun. 318:862-867.
17. Laskowski, R. A. 1995. SURFNET: a program for visualizing molecular surfaces, cavities, and intermolecular interactions. J. Mol. Graph. 13:323-328.
18. Laskowski, R. A., M. W. MacArthur, D. S. Moss, and J. M. Thornton. 1993. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26:283-291.
19. Lee, T. W., M. M. Cherney, C. Huitema, J. Liu, K. E. James, J. C. Powers, L. D. Eltis, and M. N. James. 2005. Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide. J. Mol. Biol. 353:1137-1151.
20. Lee, T. W., M. M. Cherney, J. Liu, K. E. James, J. C. Powers, L. D. Eltis, and M. N. James. 2007. Crystal structures reveal an induced-fit binding of a substrate-like Aza-peptide epoxide to SARS coronavirus main peptidase. J. Mol. Biol. 366:916-932.
21. McCoy, A. J., R. W. Grosse-Kunstleve, L. C. Storoni, and R. J. Read. 2005. Likelihood-enhanced fast translation functions. Acta Crystallogr. D 61:458-464.
22. Otwinowski, Z., and W. Minor. 1997. Processing of x-ray diffraction data collected in oscillation mode, p. 307-326. In C. W. Carter, Jr., and R. M. Sweet (ed.), Methods in enzymology, vol. 276. Academic Press, New York, NY.
23. Pang, Y. P. 2004. Three-dimensional model of a substrate-bound SARS chymotrypsin-like cysteine proteinase predicted by multiple molecular dynamics simulations: catalytic efficiency regulated by substrate binding. Proteins 57:747-757.
24. Schuck, P. 2000. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys. J. 78:1606-1619.
25. Shi, J., and J. Song. 2006. The catalysis of the SARS 3C-like protease is under extensive regulation by its extra domain. FEBS J. 273:1035-1045.
26. Shi, J., Z. Wei, and J. Song. 2004. Dissection study on the severe acute respiratory syndrome 3C-like protease reveals the critical role of the extra domain in dimerization of the enzyme: defining the extra domain as a new target for design of highly specific protease inhibitors. J. Biol. Chem. 279:24765-24773.
27. Tan, J., K. H. Verschueren, K. Anand, J. Shen, M. Yang, Y. Xu, Z. Rao, J. Bigalke, B. Heisen, J. R. Mesters, K. Chen, X. Shen, H. Jiang, and R. Hilgenfeld. 2005. pH-dependent conformational flexibility of the SARS-CoV main proteinase (M(pro)) dimer: molecular dynamics simulations and multiple X-ray structure analyses. J. Mol. Biol. 354:25-40.
28. Wei, P., K. Fan, H. Chen, L. Ma, C. Huang, L. Tan, D. Xi, C. Li, Y. Liu, A. Cao, and L. Lai. 2006. The N-terminal octapeptide acts as a dimerization inhibitor of SARS coronavirus 3C-like proteinase. Biochem. Biophys. Res. Commun. 339:865-872.
29. Xue, X., H. Yang, W. Shen, Q. Zhao, J. Li, K. Yang, C. Chen, Y. Jin, M. Bartlam, and Z. Rao. 2007. Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage endopeptidase for protein overproduction. J. Mol. Biol. 366:965-975.
30. Xue, X., H. Yu, H. Yang, F. Xue, Z. Wu, W. Shen, J. Li, Z. Zhou, Y. Ding, Q. Zhao, X. C. Zhang, M. Liao, M. Bartlam, and Z. Rao. 2008. Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design. J. Virol. 82:2515-2527.
31. Yang, H., M. Yang, Y. Ding, Y. Liu, Z. Lou, Z. Zhou, L. Sun, L. Mo, S. Ye, H. Pang, G. F. Gao, K. Anand, M. Bartlam, R. Hilgenfeld, and Z. Rao. 2003. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc. Natl. Acad. Sci. USA 100:13190-13195.
32. Zheng, K., G. Ma, J. Zhou, M. Zen, W. Zhao, Y. Jiang, Q. Yu, and J. Feng. 2007. Insight into the activity of SARS main protease: molecular dynamics study of dimeric and monomeric form of enzyme. Proteins 66:467-479.